Trying to build a portfolio that can survive recessions, inflation, and market volatility is one of the biggest challenges any investor can face. Unexpected market moves are hard to predict, and if…
Pre-Market Stock Futures: The stock futures are trading lower on Thursday, following another incredible day for the Dow Jones Industrials, while the rotation out of the NASDAQ and into technology is still…
Pre-Market Futures: The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir’s 6.9% decline despite beating earnings expectations and giving strong forward guidance. Concerns over an AI…
At 24/7 Wall St., we have closely followed dividend-paying stocks for over 15 years. With a growing audience of savvy Baby Boomers and retirees seeking safe income ideas that deliver more than…
Over the past 11 years, I’ve built a portfolio centered on steady dividend payers, stocks that deliver reliable income quarter after quarter. No drama, no surprises — just consistent checks hitting my…
Geopolitical events, judicial rulings, new law legislation, and policy changes are all circumstances occurring on domestic and international stages that are triggering big stock moves in various industrial sectors. The impact is…
Starting today, the U.S. imposed 100% tariffs on imports of branded or patented pharmaceutical products that President Trump announced last week. This sweeping measure targets foreign-made drugs to push manufacturers toward U.S.…
If you are looking for a source of income that outlives you, look into dividend ETFs that are time-tested over decades. The stock market today looks nothing like the stock market two…
Why Dividend Growth Investing Builds Lasting Wealth In the world of investing, few strategies match the quiet power of dividend growth for long-term wealth accumulation. Unlike chasing hot growth stocks that can…
With all of the attention focused on the Magnificent 7 tech stocks, AI, and biotech stocks that are all high flying and turbo charging the S&P 500, it’s easy to overlook other…
Jim Cramer may not always have the best calls, but he’s not a bad guru to look to if you want some ideas for dividend investing. On Mad Money, most of his…
These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold them for years.
Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
If you’re someone who doesn’t like to research individual stocks to generate long-term returns, exchange-traded funds can be your ideal choice. They allow you to build a diversified portfolio at low cost.…
There’s really no such thing as a “no brainer” stock pick. I’d say that some opportunities are more compelling than others. But when valuations are as high as they are (such as…
